About MicroGen Diagnostics
MicroGen Diagnostics is a company based in Orlando (United States) founded in 2011 by Randall Wolcott. MicroGen Diagnostics has raised $1.65 million across 1 funding round. MicroGen Diagnostics has completed 2 acquisitions, including CaptiGen and RTLGenomics. MicroGen Diagnostics offers products and services including qPCR + NGS Testing and Infection Finder. MicroGen Diagnostics operates in a competitive market with competitors including Kallyope, Manus Bio, OxThera, BioCorteX and Biotia, among others.
- Total Equity Funding$1.65M (USD)
in 1 rounds
- Latest Funding Round$1.65M (USD), Seed
Apr 2017
- Investments & AcquisitionsCaptiGen
& 1 more
Products & Services of MicroGen Diagnostics
MicroGen Diagnostics offers a comprehensive portfolio of products and services, including qPCR + NGS Testing and Infection Finder.
Advanced DNA testing to detect infections in clinical samples accurately.
Platform for identifying infection locations and providers quickly.
Apps and channels of MicroGen Diagnostics
its YouTube channel MicroGenDX has 1.57K subscribers and 30 videos.
Videos from MicroGen Diagnostics
The most watched videos on MicroGen Diagnostics's YouTube channel, MicroGenDX (1.57K subscribers). Click a video to play it here.
More on MicroGenDX.
Funding Insights of MicroGen Diagnostics
MicroGen Diagnostics has successfully raised a total of $1.65M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.65 million completed in April 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.65M
- Total Rounds 1
- Last Round Seed — $1.65M
- First Round $1.65M
(Apr 2017)
All 1 funding rounds of MicroGen Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2017 | $1.65M | Seed | – | – | – |
People of MicroGen Diagnostics
25 people are tracked at MicroGen Diagnostics (8 in leadership, 17 in team).
| Name | Role | Group |
|---|---|---|
Randall Wolcott | Founder | Leadership |
Rick Martin | CEO | Leadership |
Ken Perry | Director Of Business Development | Leadership |
Eric Rees | Chief Technology Officer | Leadership |
Kerstin Martin | Director Of Customer Service | Leadership |
Lars Koenig | Director Of Software Development | Leadership |
Joe Trefz | Regional Director, Business Development | Leadership |
Ewald Kreid | Managing Director Europe | Leadership |
Tara Hicks | Account Executive | Team |
Brian Rizzo | Senior Sales | Team |
Alejandro Correa | Department Manager - Inside Sales | Team |
Karenn Ayala-Montalvo | Account Executive | Team |
Steve Brennan | Independent Sales Agent - Latin America | Team |
Bill Trujillo | Molecular Sales - Next Generation Sequencing And PCR | Team |
Luis Lopez | Senior Account Executive | Team |
Rajasree Punneth Radhakrishnan | Software Developer | Team |
Astrid R. Zarate | Sales Professional | Team |
Dave Roye | Software Developer | Team |
Bethany Cummings | Customer Service Team Lead | Team |
Matthew Conrath | Territory Sales Specialist | Team |
5 more people are available in the full profile.
Complete people profiles for MicroGen Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MicroGen Diagnostics
MicroGen Diagnostics has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include CaptiGen and RTLGenomics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
A swab-based device for microbial sampling and testing is developed. | captigen.net | Philadelphia, United States | 2018 | Apr 2022 | •••• | |
Laboratory services in NGS, bioinformatics, and biostatistics are provided. | rtlgenomics.com | Lubbock, United States | 2007 | Jun 2021 | •••• |
Complete acquisition details for MicroGen Diagnostics
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of MicroGen Diagnostics
4 dated milestones of MicroGen Diagnostics across 11 years, from founding to its latest funding, stage changes and deals.
- Founded MicroGen Diagnostics is founded.
- Funding First funding round of $1.6M.
- Acquisition Acquires RTLGenomics.
- Acquisition Acquires CaptiGen.
Competitors of MicroGen Diagnostics
MicroGen Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kallyope, Manus Bio, OxThera, BioCorteX and Biotia, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| kallyope.com | 2014 | New York, United States | $479M | 84 | The gut-brain axis is explored for therapeutic and nutritional innovations. | |
| manusbio.com | 2011 | Cambridge, United States | $115.93M | – | Phytochemicals are developed using microbial fermentation processes. | |
| oxthera.com | 2005 | Stockholm, Sweden | $93.1M | – | Microbial-based drug products for hyperoxaluria treatment are developed. | |
| biocortex.com | 2021 | London, United Kingdom | $5M | – | Human-microbiome platform is developed for drug discovery applications. | |
| biotia.io | 2016 | Brooklyn, United States | $10.4M | – | Sequencing-based solutions are provided for hospitals to combat infections. | |
| adapsyn.com | 2016 | Hamilton, United States | – | – | Provider of computational tools for bacterial metabolomic and genomic data analysis | |
| kaleido.com | 2015 | Cambridge, United States | $101M | 81 | Develops innovative microbiome-based therapies for treating inflammatory conditions. | |
| chainbiotech.com | 2014 | Nottingham, United Kingdom | $5.88M | 12 | Microbiome-based oral immunotherapies are developed via CADD platform. | |
| mbiomics.com | 2020 | Munich, Germany | $14.04M | – | Genomic platforms for microbiome therapeutics development are provided. | |
| bio-me.com | 2016 | Oslo, Norway | $1.32M | – | Precision platform for gut microbiome analysis at strain-level is developed. |
Detailed competitors of MicroGen Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of MicroGen Diagnostics
The website of MicroGen Diagnostics (microgendx.com) receives about 90.1K visits a month.
- Monthly visits90.1K
▲ 31.3% vs previous month
Websites whose visitors overlap most with MicroGen Diagnostics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| oraldna.com | 100% | 7.1K | #3,709,579 | View details | |
| mylabbox.com | 97% | 65.3K | #554,610 | View details | |
| directlabs.com | 89% | – | #751,525 | View details | |
| juno.bio | 89% | 11.6K | #1,612,665 | View details | |
| viome.com | 84% | 255.1K | #139,929 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 19 similar websites and full traffic analytics for MicroGen Diagnostics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 19 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Microgen Diagnostics
Complete news archive for MicroGen Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to MicroGen Diagnostics
10 companies that operate in the same segment as MicroGen Diagnostics (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about MicroGen Diagnostics
MicroGen Diagnostics was founded in 2011 and raised its 1st funding round 6 years after it was founded.
MicroGen Diagnostics is headquartered in Orlando, United States. It is registered at Orlando, Florida, United States.
Rick Martin is the current CEO of MicroGen Diagnostics.
MicroGen Diagnostics is a funded company, having raised a total of $1.65M across 1 funding round to date. The company's 1st funding round was a Seed of $1.65M, raised on Apr 2017.
MicroGen Diagnostics was founded in 2011 and is based in Orlando, United States. Molecular diagnostics and sequencing services are offered in the healthcare sector, with a focus on infectious disease detection. Operations include PCR rapid screening, diagnostic panels, next-generation sequencing for identifying microbial organisms and fungal pathogens, and respiratory viral panels. These services support clinical and research applications in pathogen identification.
MicroGen Diagnostics offers qPCR + NGS Testing and Infection Finder.
MicroGen Diagnostics has made 2 acquisitions, including CaptiGen, and RTLGenomics.